{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:50:49Z","timestamp":1787259049406,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20242BAB20391"],"award-info":[{"award-number":["20242BAB20391"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018634","name":"State Key Laboratory of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cyto.2026.157115","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T12:49:25Z","timestamp":1768049365000},"page":"157115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IGF-1 upregulates IL-36\u03b1 expression via NF-\u03baB and p38 MAPK pathways to promote inflammation in thyroid eye disease"],"prefix":"10.1016","volume":"199","author":[{"given":"Jun","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2026.157115_bb0005","doi-asserted-by":"crossref","unstructured":"Drui D, Du Pasquier Fediaevski L, Vignal Clermont C, et al. Graves' orbitopathy: Diagnosis and treatment. Ann Endocrinol (Paris). 2018; 79: 656\u2013664.","DOI":"10.1016\/j.ando.2018.08.005"},{"key":"10.1016\/j.cyto.2026.157115_bb0010","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","article-title":"Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and re-treatment: OPTIC-X study","volume":"129","author":"Douglas","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cyto.2026.157115_bb0015","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/thy.2023.0656","article-title":"Long-term efficacy of teprotumumab in thyroid eye disease: follow-up outcomes in three clinical trials","volume":"34","author":"Kahaly","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/j.cyto.2026.157115_bb0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cyto.2026.157115_bb0025","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1038\/s41433-020-01297-w","article-title":"Teprotumumab for non-inflammatory thyroid eye disease (TED): evidence for increased IGF-1R expression","volume":"35","author":"Ugradar","year":"2021","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.cyto.2026.157115_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/br.2021.1452","article-title":"Elevated levels of serum IL-36\u03b1 in patients with systemic lupus erythematosus","volume":"15","author":"Wang","year":"2021","journal-title":"Biomed Rep."},{"key":"10.1016\/j.cyto.2026.157115_bb0035","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","article-title":"The novel cytokine interleukin-36\u03b1 is expressed in psoriatic and rheumatoid arthritis synovium","volume":"72","author":"Frey","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cyto.2026.157115_bb0040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/cei.12644","article-title":"Interleukin-36\u03b1 axis is modulated in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"181","author":"Ciccia","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2026.157115_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155921","article-title":"Interleukin-36\u03b1 is elevated in diffuse systemic sclerosis and may potentiate fibrosis","volume":"156","author":"O'Reilly","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157115_bb0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2026.157115_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fendo.2018.00591","article-title":"Elevated Interleukin-36\u03b1 And CD4(+)IL-36\u03b1(+)T Cells Are Involved in the Pathogenesis of Graves\u2019 Disease","volume":"9","author":"Yao","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cyto.2026.157115_bb0060","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2026.157115_bb0065","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157115_bb0070","doi-asserted-by":"crossref","first-page":"e3125","DOI":"10.1210\/clinem\/dgab154","article-title":"IL-38 exerts anti-inflammatory and antifibrotic effects in thyroid-associated ophthalmopathy","volume":"106","author":"Shi","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2026.157115_bb0075","doi-asserted-by":"crossref","first-page":"19588","DOI":"10.3390\/molecules201019588","article-title":"Elevated expression and pro-inflammatory activity of IL-36 in patients with systemic lupus erythematosus","volume":"20","author":"Chu","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.cyto.2026.157115_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2018.03.011","article-title":"Increased serum IL-36\u03b1 and IL-36\u03b3 levels in patients with systemic lupus erythematosus: association with disease activity and arthritis","volume":"58","author":"Mai","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cyto.2026.157115_bb0085","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10753-022-01733-x","article-title":"Plasma IL-36\u03b1 and IL-36\u03b3 as potential biomarkers in interstitial lung disease associated with rheumatoid arthritis: a pilot study in the Chinese population","volume":"46","author":"Zheng","year":"2023","journal-title":"Inflammation"},{"key":"10.1016\/j.cyto.2026.157115_bb0090","first-page":"11","article-title":"Plasma levels of interleukins 36\u03b1, 36\u03b2, and 37 in patients with psoriasis and their correlation with disease activity parameters","author":"S\u0142ucznowska-G\u0142abowska","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cyto.2026.157115_bb0095","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.2147\/COPD.S357151","article-title":"IL-36 is closely related to neutrophilic inflammation in chronic obstructive pulmonary disease","volume":"17","author":"Huang","year":"2022","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"10.1016\/j.cyto.2026.157115_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12865-024-00613-3","article-title":"Potential role of IGF-1R in the interaction between orbital fibroblasts and B lymphocytes: an implication for B lymphocyte depletion in the active inflammatory phase of thyroid-associated ophthalmopathy","volume":"25","author":"Wang","year":"2024","journal-title":"BMC Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2026.157115_bb0105","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/thy.2024.0529","article-title":"Targeting the aryl hydrocarbon receptor to attenuate IGF1R Signaling in thyroid eye disease","volume":"35","author":"Roztocil","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.cyto.2026.157115_bb0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cyto.2016.05.012","article-title":"Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines","volume":"84","author":"Dietrich","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2026.157115_bb0115","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/en.2015-1399","article-title":"Pentraxin-3 is a TSH-inducible protein in human fibrocytes and orbital fibroblasts","volume":"156","author":"Wang","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.cyto.2026.157115_bb0120","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1167\/iovs.18-23951","article-title":"CD34- orbital fibroblasts from patients with thyroid-associated ophthalmopathy modulate TNF-\u03b1 expression in CD34+ fibroblasts and fibrocytes","volume":"59","author":"Lu","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cyto.2026.157115_bb0125","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2026.157115_bb0130","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2026.157115_bb0135","doi-asserted-by":"crossref","first-page":"E1635","DOI":"10.1210\/jc.2014-1580","article-title":"Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes","volume":"99","author":"Chen","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2026.157115_bb0140","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1210\/jc.2011-2890","article-title":"A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves\u2019 orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody","volume":"97","author":"Kumar","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2026.157115_bb0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40618-020-01380-9","article-title":"Thyrotropin receptor antibodies and graves\u2019 orbitopathy","volume":"44","author":"Diana","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cyto.2026.157115_bb0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.21037\/cdt.2019.07.12","article-title":"Combination of HGF and IGF-1 promotes connexin 43 expression and improves ventricular arrhythmia after myocardial infarction through activating the MAPK\/ERK and MAPK\/p38 signaling pathways in a rat model","volume":"9","author":"Yao","year":"2019","journal-title":"Cardiovasc Diagn Ther."},{"key":"10.1016\/j.cyto.2026.157115_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061649","article-title":"Effects of cyclic mechanical stretch on the proliferation of L6 myoblasts and its mechanisms: PI3K\/Akt and MAPK signal pathways regulated by IGF-1 receptor","volume":"19","author":"Fu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cyto.2026.157115_bb0160","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/jcmm.13574","article-title":"Transplant of insulin-like growth factor-1 expressing bone marrow stem cells improves functional regeneration of injured rat uterus by NF-\u03baB pathway","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cyto.2026.157115_bb0165","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","article-title":"IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation","volume":"9","author":"Russell","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.cyto.2026.157115_bb0170","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/crj.13338","article-title":"Elevated sputum IL-36 levels are associated with neutrophil-related inflammation in COPD patients","volume":"15","author":"Li","year":"2021","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.cyto.2026.157115_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcell.2019.00317","article-title":"Function and regulation of IL-36 Signaling in inflammatory diseases and Cancer development","volume":"7","author":"Queen","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.cyto.2026.157115_bb0180","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3389\/fimmu.2019.02532","article-title":"Biology of IL-36 Signaling and its role in systemic inflammatory diseases","volume":"10","author":"Yuan","year":"2019","journal-title":"Front. Immunol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466626000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T11:41:25Z","timestamp":1770205285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466626000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"alternative-id":["S1043466626000104"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157115","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-1 upregulates IL-36\u03b1 expression via NF-\u03baB and p38 MAPK pathways to promote inflammation in thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2026.157115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157115"}}